Videos

Lowell L. Hart, MD, FACP, discusses the utility of antibody-drug conjugates in HER2-positive breast cancer.

Dr. Hart on Antibody-Drug Conjugates in HER2+ Breast Cancer

Articles

While major accomplishments in blood and marrow transplantation (BMT) were
being made around the country, the first BMT
program at Wake Forest Baptist came into view,
a vision brought to life by David D. Hurd, MD.

Marking 25 Years of Progress in Blood and Marrow Transplantation

Active research and advancements in the field focuses on lessening the burden of radiation treatment while still maintaining acceptable cosmetic outcomes for patients with breast cancer.

Short Course Radiation Treatment for Breast Cancer

The rise in survivorship has increased chronic pain in the cancer pain population, the treatment of which has many fundamental differences when compared to acute and terminal cancer pain. 

Survivorship and Chronic Pain Management for Cancer Pain

The lack of comprehensive rehabilitation services is a profound source of unnecessary suffering for survivors.

Impairment-Driven Cancer Rehabilitation Improves Survivors' Quality of Life

Determination of BRCA1 and 2 mutation carrier status has become increasingly important. Estimates suggest that about 80% of breast cancers and 90% of ovarian cancers are sporadic; while only 5% to 10% of breast cancers are hereditary. 

Wake Forest Baptist Health

Latest from Wake Forest Baptist Health

New content coming soon, please check back later.